Article
India's Draft Biotech Patent Guidelines: What U.S. Applicants Should Know Now
India's Patent Office has released draft biotechnology examination guidelines that fundamentally reshape how U.S. patent practitioners should approach Indian filings. With strict limits on claim amendments and new standards for diagnostics, efficacy data, and enablement, the window to optimize claims closes at PCT national-phase entry—making pre-filing strategy more critical than ever.
Barnes & Thornburg LLP